SOD1 and colitis: Our study showed that the FEC treatment group could inhibit colitis by regulating anti-oxidant mediators and inhibiting SOD, CAT, and GSH productions, which means FEC might exhibit anti-UC activity through anti-oxidant activity, and the anti-oxidant activity was better when a higher dose of FEC was given.